Arbutus Biopharma Corp Annual Nonoperating Income (Expense) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Arbutus Biopharma Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
  • Arbutus Biopharma Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.79M, a 38.4% increase year-over-year.
  • Arbutus Biopharma Corp Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $6.16M, a 90.3% increase year-over-year.
  • Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2023 was $5.25M, a 1083% increase from 2022.
  • Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2022 was $444K.
  • Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2021 was -$2.73M, a 54.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.25M +$4.81M +1083% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $444K +$3.17M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$2.73M +$3.21M +54.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$5.94M +$16.5M +73.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$22.5M -$50.9M -179% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $28.4M +$26.2M +1194% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $2.2M -$276K -11.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $2.47M -$22.5M -90.1% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $25M +$30.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 -$5.4M -$3.49M -183% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-22
2013 -$1.91M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.